ASSIGNMENT OF PATIENTS (/9) | 9 | 9 | 7 | 9 | 9 | 9 | 5 | 9 | 7 | 7 | 9 | 5 | 5 | 5 | 4 | 4 |
BASELINE VALUES OF GROUPS (/8) | 8 | 8 | 4 | 8 | 4 | 8 | 8 | 8 | 8 | 4 | 0 | 8 | 0 | 4 | 4 | 0 |
RELEVANCE OF OUTCOMES & CLINICAL SIGNIFICANCE (/7) | 7 | 7 | 7 | 3 | 7 | 3 | 7 | 5 | 7 | 7 | 7 | 5 | 7 | 3 | 3 | 3 |
PROGNOSTIC STRATIFICATION (COMORBIDITY AND RISK FACTORS) (/6) | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 3 | 6 | 3 | 0 | 6 | 6 | 6 | 6 | 6 |
BLINDING STRATEGIES (/5) | 5 | 3 | 5 | 3 | 3 | 3 | 3 | 2 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 |
CONTAMINATION/CO-INTERVENTION (/4) | 4 | 3 | 4 | 4 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
COMPLIANCE OF SUBJECTS TO STUDY PROCEDURES (/4) | 3 | 3 | 4 | 2 | 2 | 2 | 2 | 4 | 1 | 0 | 4 | 1 | 0 | 0 | 0 | 1 |
DROP-OUT RATES OF SUBJECTS (/3) | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 0 | 0 | 3 | 3 | 0 | 3 |
FOLLOW-UP LEVELS (/2) | 2 | 2 | 1 | 2 | 2 | 1 | 2 | 0 | 1 | 2 | 2 | 0 | 0 | 0 | 1 | 0 |
DATE OF PUBLICATION (/1) | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 1 |
TOTAL (/50) | 48 | 45 | 42 | 41 | 37 | 37 | 36 | 34 | 33 | 27 | 26 | 25 | 22 | 21 | 19 | 18 |